CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine

被引：18
|
作者：
Capi, Matilde [1 ]
De Angelis, Valerio [2 ]
De Bernardini, Donatella [1 ]
De Luca, Ottavia [3 ]
Cipolla, Fabiola [2 ]
Lionetto, Luana [1 ]
Simmaco, Maurizio [1 ,3 ,4 ]
Martelletti, Paolo [2 ]
机构：
[1] St Andrea Univ Hosp, Mass Spectrometry Unit, Lab Clin Biochem, I-00185 Rome, Italy
[2] Sapienza Univ Rome, Dept Clin & Mol Med, I-00185 Rome, Italy
[3] St Andrea Univ Hosp, Adv Mol Diagnost Unit, Lab Clin Biochem, I-00185 Rome, Italy
[4] Sapienza Univ, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, I-00185 Rome, Italy
来源：
JOURNAL OF CLINICAL MEDICINE | 2021年 / 10卷 / 07期
关键词：
migraine; CGRP; therapy; gepants; ditans; antagonism; CGRP receptor; GENE-RELATED PEPTIDE; MONOCLONAL-ANTIBODIES; SAFETY PROFILE; LASMIDITAN;
D O I：
10.3390/jcm10071429
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Discovering that calcitonin-related peptide (CGRP) plays a key role in the complex pathophysiology of migraine has allowed us to make great strides in the development of new approaches for acute and preventive treatment. This evidence has led to the development of small molecules antagonist molecules of the CGRP receptor ("gepants") and of a new class of medications called "Ditans". This review presents the data from clinical trials reporting the efficacy, safety, and tolerability of the new drugs used in the treatment of migraines. Evidences show that therapeutic approaches targeted to CGRP have the potential to transform the clinical management of migraine, even though its appropriate place has yet to be determined with accuracy.
引用
收藏
页数：17
相关论文
共 50 条
  • [21] Targeted 5-HT1F Therapies for Migraine
    Marta Vila-Pueyo
    Neurotherapeutics, 2018, 15 : 291 - 303
  • [22] Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment
    Maggioni, Ferdinando
    Pini, Luigi Alberto
    Zanchin, Giorgio
    CEPHALALGIA, 2011, 31 (09) : 1061 - 1061
  • [23] Caprolactams as potent CGRP receptor antagonists for the treatment of migraine
    Shaw, Anthony W.
    Paone, Daniel V.
    Nguyen, Diem N.
    Stump, Craig A.
    Burgey, Christopher S.
    Mosser, Scott D.
    Salvatore, Christopher A.
    Rutledge, Ruth Z.
    Kane, Stefanie A.
    Koblan, Kenneth S.
    Graham, Samuel L.
    Vacca, Joeseph P.
    Williams, Theresa M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (17) : 4795 - 4798
  • [24] The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine
    Raffaelli, Bianca
    Israel, Heike
    Neeb, Lars
    Reuter, Uwe
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (13) : 1409 - 1415
  • [25] Chromosomal localization of the 5-HT1F receptor gene:: No evidence for involvement in response to sumatriptan in migraine patients
    VanDenBrink, AM
    Vergouwe, MN
    Ophoff, RA
    Naylor, SL
    Dauwerse, HG
    Saxena, PR
    Ferrari, MD
    Frants, RR
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 77 (05): : 415 - 420
  • [26] CGRP receptor antagonists for migraine. Are they also AMY1 receptor antagonists?
    Garelja, Michael L.
    Walker, Christopher S.
    Hay, Debbie L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (03) : 454 - 459
  • [27] Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis
    Hou, Min
    Xing, Haiyan
    Li, Chen
    Wang, Xianfeng
    Deng, Dongmei
    Li, Juan
    Zhang, Pan
    Chen, Jianhong
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [28] Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis
    Min Hou
    Haiyan Xing
    Chen Li
    Xianfeng Wang
    Dongmei Deng
    Juan Li
    Pan Zhang
    Jianhong Chen
    The Journal of Headache and Pain, 2020, 21
  • [29] Amerge -: 5-HT1 receptor agonist for acute treatment of migraine attacks
    不详
    FORMULARY, 1998, 33 (04) : 280 - 280
  • [30] Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan
    Rubio-Beltran, Eloisa
    Labastida-Ramirez, Alejandro
    Haanes, Kristian A.
    van den Bogaerdt, Antoon
    Bogers, Ad J. J. C.
    Zanelli, Eric
    Meeus, Laurent
    Danser, A. H. Jan
    Gralinski, Michael R.
    Senese, Peter B.
    Johnson, Kirk W.
    Kovalchin, Joseph
    Villalon, Carlos M.
    MaassenVanDenBrink, Antoinette
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (24) : 4681 - 4695
12345